Tag: genomics
-
Bacteria Traffic Tracked in New Hospital
The opening of a new hospital in Chicago offered an opportunity to follow the formation of bacterial communities and their movement in a health care facility.
-
Broad Inst., Intel Make Genomics Software Open-Source
A new release of software that speeds and streamlines analysis of genomic sequencing variations is being released under an open-source license by the Broad Institute.
-
Trial to Test Spherical Nanotech Brain Cancer Drug
An early-stage clinical trial will soon begin testing spherically-shaped nanoscale particles to treat glioblastoma, an aggressive form of brain cancer.
-
Trial to Examine Immune System Workings
Unlike conventional clinical studies testing a particular treatment, this trial aims to explore in more detail the body’s interactions with a class of drugs, in this case vaccines.
-
Gene Therapy Start-Up Raises $41M in Early Funds
A 1 year-old enterprise developing gene therapies to treat rare inherited metabolic disorders is raising €37.5 million ($US 40.8 million) in its first venture funding round.
-
23andMe, Grünenthal Partner on Pain Genetics
A personal genetics company in Silicon Valley is collaborating with a German pharmaceutical company to better understand the relationship between genetics and pain.
-
Crispr, Stem Cells Produce Precise Arthritis Therapy
Editing the genes in stem cells is shown to produce cartilage that in lab tests releases therapeutic proteins only when needed to relieve joint inflammation in arthritis.
-
Crispr-Based Diagnostics System Designed
A bioengineering team from Harvard University and Massachusetts Institute of Technology designed simple, inexpensive diagnostics tools to detect infectious diseases, based on Crispr, an emerging genome-editing technology.
-
Corn, Shellfish Ingredients Enable DNA Vaccine Pills
Biomaterials researchers discovered substances from corn and shellfish can package genetic material to pass through the digestive system, making possible vaccines as pills rather than injections.
-
Engineered Bacteria Designed to Detect Gut Inflammation
A bioengineering team at Rice University developed a genetically modified form of bacteria that in lab mice detects inflammatory diseases in the gut.